{"id":395,"date":"2021-03-30T14:05:00","date_gmt":"2021-03-30T14:05:00","guid":{"rendered":"https:\/\/www.everpharma.com\/portfolio\/docetaxel-ever-valinject\/"},"modified":"2025-05-21T10:35:31","modified_gmt":"2025-05-21T10:35:31","slug":"docetaxel-ever-valinject","status":"publish","type":"product","link":"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/","title":{"rendered":"Docetaxel"},"content":{"rendered":"\n<div class=\"wp-block-group meta\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group meta\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong><strong>Darreichungsform<\/strong><\/strong><\/td><td>Konzentrat zur Herstellung einer Infusionsl\u00f6sung<\/td><\/tr><tr><td><strong><strong>Wirkst\u00e4rke<\/strong><\/strong><\/td><td>20 mg\/ml<\/td><\/tr><tr><td><strong><strong><strong>St\u00e4rke pro Einheit<\/strong><\/strong><\/strong><\/td><td>20 mg\/1 ml, 80 mg\/4 ml, 160 mg\/8 ml<\/td><\/tr><tr><td><strong>ATC Code <\/strong><\/td><td>L01CD02<\/td><\/tr><tr><td><strong><strong>Wirkstoffklasse<\/strong><\/strong><\/td><td>Taxane<\/td><\/tr><tr><td><strong><strong>Indikation<\/strong><\/strong><\/td><td><strong>Brustkrebs<br><\/strong>Docetaxel EVER Valinject ist in Kombination mit Doxorubicin und Cyclophosphamid angezeigt f\u00fcr die <br>adjuvante Therapie von Patientinnen mit:<br>&#8211; operablem, nodal positivem Brustkrebs,<br>&#8211; operablem, nodal negativem Brustkrebs.<strong><br><\/strong>Bei Patientinnen mit operablem, nodal negativem Brustkrebs sollte die adjuvante Therapie auf solche <br>Patientinnen beschr\u00e4nkt werden, die f\u00fcr eine Chemotherapie gem\u00e4\u00df den international festgelegten Kriterien <br>zur Prim\u00e4rtherapie von Brustkrebs in fr\u00fchen Stadien infrage kommen (siehe Abschnitt 5.1).<strong><br><\/strong>Docetaxel EVER Valinject ist in Kombination mit Doxorubicin zur Behandlung von Patientinnen mit lokal <br>fortgeschrittenem oder metastasiertem Brustkrebs ohne vorausgegangene Chemotherapie angezeigt.<strong><br><\/strong>Die Docetaxel EVER Valinject-Monotherapie ist zur Behandlung von Patientinnen mit lokal <br>fortgeschrittenem oder metastasiertem Brustkrebs nach Versagen einer Chemotherapie angezeigt. <br>Die vorausgegangene Chemotherapie sollte ein Anthracyclin oder Alkylanzien enthalten haben.<strong><br><\/strong>Docetaxel EVER Valinject ist in Kombination mit Trastuzumab angezeigt zur Behandlung von Patientinnen <br>mit metastasiertem Mammakarzinom, deren Tumore HER2 \u00fcberexprimieren und die vorher noch keine <br>Chemotherapie gegen ihre metastasierte Erkrankung erhalten haben.<br>Docetaxel EVER Valinject ist in Kombination mit Capecitabin zur Behandlung von Patientinnen mit lokal <br>fortgeschrittenem oder metastasiertem Brustkrebs nach Versagen einer Chemotherapie angezeigt. Die fr\u00fchere <br>Behandlung sollte ein Anthracyclin enthalten haben.<strong><br>Nicht-kleinzelliges Bronchialkarzinom<br><\/strong>Docetaxel EVER Valinject ist zur Behandlung von Patienten mit lokal fortgeschrittenem oder metastasiertem, <br>nicht kleinzelligem Bronchialkarzinom nach Versagen einer vorausgegangenen Chemotherapie angezeigt.<strong><br><\/strong>Docetaxel EVER Valinject ist in Kombination mit Cisplatin zur Behandlung von Patienten mit nicht resezierbarem, <br>lokal fortgeschrittenem oder metastasiertem, nicht kleinzelligem Bronchialkarzinom ohne vorausgegangene <br>Chemotherapie angezeigt.<strong><br>Prostatakarzinom<br><\/strong>Docetaxel EVER Valinject ist in Kombination mit Prednison oder Prednisolon zur Behandlung von Patienten mit <br>hormonrefrakt\u00e4rem metastasiertem Prostatakarzinom angezeigt.<strong><br>Adenokarzinom des Magens<br><\/strong>Docetaxel EVER Valinject ist in Kombination mit Cisplatin und 5-Fluorouracil angezeigt zur Behandlung von <br>Patienten mit metastasiertem Adenokarzinom des Magens, einschlie\u00dflich Adenokarzinom der gastro\u00f6sophagealen <br>\u00dcbergangszone, die keine vorherige Chemotherapie gegen ihre metastasierte Erkrankung erhalten haben.<strong><br>Kopf-Hals-Karzinome<br><\/strong>Docetaxel EVER Valinject ist in Kombination mit Cisplatin und 5-Fluorouracil f\u00fcr die Induktionstherapie von <br>Patienten mit lokal fortgeschrittenem Plattenepithelkarzinom im Kopf-Hals-Bereich angezeigt.<\/td><\/tr><tr><td><strong>CytoWrap\u00ae<\/strong><\/td><td>Vials k\u00f6nnen mit einer Schutzh\u00fclle versehen werden.<br><img loading=\"lazy\" decoding=\"async\" width=\"1131\" height=\"344\" class=\"wp-image-4424\" style=\"width: 150px\" src=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/03\/Logo_CytoWrap_EVER.png\" alt=\"CytoWrap Logo\" srcset=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/03\/Logo_CytoWrap_EVER.png 1131w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/03\/Logo_CytoWrap_EVER-300x91.png 300w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/03\/Logo_CytoWrap_EVER-1024x311.png 1024w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/03\/Logo_CytoWrap_EVER-768x234.png 768w\" sizes=\"auto, (max-width: 1131px) 100vw, 1131px\" \/><\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-2 is-layout-flex wp-block-gallery-is-layout-flex\">\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"2000\" height=\"2000\" data-id=\"2589\" src=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_20mg_1ml_front_mirrored_DE.jpg\" alt=\"\" class=\"wp-image-2589\" srcset=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_20mg_1ml_front_mirrored_DE.jpg 2000w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_20mg_1ml_front_mirrored_DE-300x300.jpg 300w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_20mg_1ml_front_mirrored_DE-1024x1024.jpg 1024w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_20mg_1ml_front_mirrored_DE-150x150.jpg 150w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_20mg_1ml_front_mirrored_DE-768x768.jpg 768w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_20mg_1ml_front_mirrored_DE-1536x1536.jpg 1536w\" sizes=\"auto, (max-width: 2000px) 100vw, 2000px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"2000\" height=\"2000\" data-id=\"2591\" src=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_80mg_1ml_front_mirrored_DE.jpg\" alt=\"\" class=\"wp-image-2591\" srcset=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_80mg_1ml_front_mirrored_DE.jpg 2000w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_80mg_1ml_front_mirrored_DE-300x300.jpg 300w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_80mg_1ml_front_mirrored_DE-1024x1024.jpg 1024w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_80mg_1ml_front_mirrored_DE-150x150.jpg 150w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_80mg_1ml_front_mirrored_DE-768x768.jpg 768w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_80mg_1ml_front_mirrored_DE-1536x1536.jpg 1536w\" sizes=\"auto, (max-width: 2000px) 100vw, 2000px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"2000\" height=\"2000\" data-id=\"2593\" src=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_160mg_1ml_front_mirrored_DE.jpg\" alt=\"\" class=\"wp-image-2593\" srcset=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_160mg_1ml_front_mirrored_DE.jpg 2000w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_160mg_1ml_front_mirrored_DE-300x300.jpg 300w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_160mg_1ml_front_mirrored_DE-1024x1024.jpg 1024w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_160mg_1ml_front_mirrored_DE-150x150.jpg 150w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_160mg_1ml_front_mirrored_DE-768x768.jpg 768w, https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/05\/Docetaxel-EVER_Pack_160mg_1ml_front_mirrored_DE-1536x1536.jpg 1536w\" sizes=\"auto, (max-width: 2000px) 100vw, 2000px\" \/><\/figure>\n<\/figure>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-base-font-size\"><em>Docetaxel EVER Pharma <em>ist ein verschreibungspflichtiges Medikament. Informationen nur f\u00fcr medizinisches Fachpersonal.<\/em><br><em>Vollst\u00e4ndige Informationen \u00fcber das Medikament finden Sie in der Fachinformation.<\/em><\/em><\/p>\n<\/div><\/div>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Darreichungsform Konzentrat zur Herstellung einer Infusionsl\u00f6sung Wirkst\u00e4rke 20 mg\/ml St\u00e4rke pro Einheit 20 mg\/1 ml, 80 mg\/4 ml, 160 mg\/8 ml ATC Code L01CD02 Wirkstoffklasse Taxane Indikation BrustkrebsDocetaxel EVER Valinject ist in Kombination mit Doxorubicin und Cyclophosphamid angezeigt f\u00fcr die adjuvante Therapie von Patientinnen mit:&#8211; operablem, nodal positivem Brustkrebs,&#8211; operablem, nodal negativem Brustkrebs.Bei Patientinnen mit &hellip; <a href=\"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/\">Weiterlesen<\/a><\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-395","product","type-product","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Docetaxel - EVER Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Docetaxel - EVER Pharma\" \/>\n<meta property=\"og:description\" content=\"Darreichungsform Konzentrat zur Herstellung einer Infusionsl\u00f6sung Wirkst\u00e4rke 20 mg\/ml St\u00e4rke pro Einheit 20 mg\/1 ml, 80 mg\/4 ml, 160 mg\/8 ml ATC Code L01CD02 Wirkstoffklasse Taxane Indikation BrustkrebsDocetaxel EVER Valinject ist in Kombination mit Doxorubicin und Cyclophosphamid angezeigt f\u00fcr die adjuvante Therapie von Patientinnen mit:&#8211; operablem, nodal positivem Brustkrebs,&#8211; operablem, nodal negativem Brustkrebs.Bei Patientinnen mit &hellip; Weiterlesen\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/\" \/>\n<meta property=\"og:site_name\" content=\"EVER Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-21T10:35:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/03\/Logo_CytoWrap_EVER.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1131\" \/>\n\t<meta property=\"og:image:height\" content=\"344\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/produkte\\\/docetaxel-ever-valinject\\\/\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/produkte\\\/docetaxel-ever-valinject\\\/\",\"name\":\"Docetaxel - EVER Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/produkte\\\/docetaxel-ever-valinject\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/produkte\\\/docetaxel-ever-valinject\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Logo_CytoWrap_EVER.png\",\"datePublished\":\"2021-03-30T14:05:00+00:00\",\"dateModified\":\"2025-05-21T10:35:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/produkte\\\/docetaxel-ever-valinject\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.everpharma.com\\\/de\\\/produkte\\\/docetaxel-ever-valinject\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/produkte\\\/docetaxel-ever-valinject\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Logo_CytoWrap_EVER.png\",\"contentUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Logo_CytoWrap_EVER.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/produkte\\\/docetaxel-ever-valinject\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Products\",\"item\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/produkte\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Docetaxel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/\",\"name\":\"EVER Pharma\",\"description\":\"Dedicated to health.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":[\"Organization\",\"MedicalOrganization\"],\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#organization\",\"name\":\"EVER Pharma\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/ever-pharma-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.everpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/ever-pharma-logo.png\",\"width\":240,\"height\":67,\"caption\":\"EVER Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.everpharma.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"legalName\":\"EVER Neuro Pharma GmbH\",\"foundingDate\":\"1934-01-01\",\"description\":\"EVER Pharma is a fully integrated specialty pharmaceuticals company specializing in the research, development, and production of sterile injectables and specialty generics for neurology, oncology, intensive care, and hormone therapeutics worldwide.\",\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"Oberburgau 3\",\"addressLocality\":\"Unterach am Attersee\",\"addressRegion\":\"Ober\u00f6sterreich\",\"postalCode\":\"4866\",\"addressCountry\":\"AT\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"contactType\":\"customer service\",\"telephone\":\"+43 7665 20555 0\",\"email\":\"office@everpharma.com\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ever-pharma\\\/\",\"https:\\\/\\\/www.wikidata.org\\\/wiki\\\/Q30268961\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Docetaxel - EVER Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/","og_locale":"de_DE","og_type":"article","og_title":"Docetaxel - EVER Pharma","og_description":"Darreichungsform Konzentrat zur Herstellung einer Infusionsl\u00f6sung Wirkst\u00e4rke 20 mg\/ml St\u00e4rke pro Einheit 20 mg\/1 ml, 80 mg\/4 ml, 160 mg\/8 ml ATC Code L01CD02 Wirkstoffklasse Taxane Indikation BrustkrebsDocetaxel EVER Valinject ist in Kombination mit Doxorubicin und Cyclophosphamid angezeigt f\u00fcr die adjuvante Therapie von Patientinnen mit:&#8211; operablem, nodal positivem Brustkrebs,&#8211; operablem, nodal negativem Brustkrebs.Bei Patientinnen mit &hellip; Weiterlesen","og_url":"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/","og_site_name":"EVER Pharma","article_modified_time":"2025-05-21T10:35:31+00:00","og_image":[{"width":1131,"height":344,"url":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/03\/Logo_CytoWrap_EVER.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/","url":"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/","name":"Docetaxel - EVER Pharma","isPartOf":{"@id":"https:\/\/www.everpharma.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/#primaryimage"},"image":{"@id":"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/#primaryimage"},"thumbnailUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/03\/Logo_CytoWrap_EVER.png","datePublished":"2021-03-30T14:05:00+00:00","dateModified":"2025-05-21T10:35:31+00:00","breadcrumb":{"@id":"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/#primaryimage","url":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/03\/Logo_CytoWrap_EVER.png","contentUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2021\/03\/Logo_CytoWrap_EVER.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.everpharma.com\/de\/produkte\/docetaxel-ever-valinject\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.everpharma.com\/de\/"},{"@type":"ListItem","position":2,"name":"Products","item":"https:\/\/www.everpharma.com\/de\/produkte\/"},{"@type":"ListItem","position":3,"name":"Docetaxel"}]},{"@type":"WebSite","@id":"https:\/\/www.everpharma.com\/de\/#website","url":"https:\/\/www.everpharma.com\/de\/","name":"EVER Pharma","description":"Dedicated to health.","publisher":{"@id":"https:\/\/www.everpharma.com\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.everpharma.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":["Organization","MedicalOrganization"],"@id":"https:\/\/www.everpharma.com\/de\/#organization","name":"EVER Pharma","url":"https:\/\/www.everpharma.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.everpharma.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2022\/07\/ever-pharma-logo.png","contentUrl":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2022\/07\/ever-pharma-logo.png","width":240,"height":67,"caption":"EVER Pharma"},"image":{"@id":"https:\/\/www.everpharma.com\/de\/#\/schema\/logo\/image\/"},"legalName":"EVER Neuro Pharma GmbH","foundingDate":"1934-01-01","description":"EVER Pharma is a fully integrated specialty pharmaceuticals company specializing in the research, development, and production of sterile injectables and specialty generics for neurology, oncology, intensive care, and hormone therapeutics worldwide.","address":{"@type":"PostalAddress","streetAddress":"Oberburgau 3","addressLocality":"Unterach am Attersee","addressRegion":"Ober\u00f6sterreich","postalCode":"4866","addressCountry":"AT"},"contactPoint":{"@type":"ContactPoint","contactType":"customer service","telephone":"+43 7665 20555 0","email":"office@everpharma.com"},"sameAs":["https:\/\/www.linkedin.com\/company\/ever-pharma\/","https:\/\/www.wikidata.org\/wiki\/Q30268961"]}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/product\/395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/types\/product"}],"wp:attachment":[{"href":"https:\/\/www.everpharma.com\/de\/wp-json\/wp\/v2\/media?parent=395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}